| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 670688 | Null | 0.0016365323975257 | 0.49047017 |
| NSC 688074 | 16,24-Cyclo-13,14-secoergost-2-ene-18,26-dioic acid, 5-chloro-14,17:14,27-diepoxy-6,13,20,22-tetrahydroxy-1,15-dioxo-, .gamma.-lactone .delta.-lactone | 0.00163653239752571 | 0.5981508 |
| NSC 682836 | Propanimidoyl chloride, N-[[[[2-(trifluoromethoxy)phenyl] amino]carbonyl]oxy]- | 0.00166185890990729 | 0.41718804 |
| NSC 715522 | Null | 0.00166185890990729 | 0.4018113 |
| NSC 720340 | Null | 0.00166185890990729 | 0.44724006 |
| NSC 726718 | 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid | 0.00166185890990729 | 0.43628931 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.00166185890990729 | 0.41644644 |
| NSC 293046 | Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide | 0.00166561193816139 | 0.48166477 |
| NSC 621968 | Null | 0.00166561193816139 | 0.44170626 |
| NSC 639503 | Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride | 0.00166561193816139 | 0.60708428 |